Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.117EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.448EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.1 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XADEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XABEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XALEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
XAY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used